Cargando…
Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165130/ https://www.ncbi.nlm.nih.gov/pubmed/32253716 http://dx.doi.org/10.1007/s40264-020-00929-0 |
| _version_ | 1783523414961553408 |
|---|---|
| author | Schaffalitzky de Muckadell, Philip Strom, Claes Christian |
| author_facet | Schaffalitzky de Muckadell, Philip Strom, Claes Christian |
| author_sort | Schaffalitzky de Muckadell, Philip |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7165130 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71651302020-04-24 Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ Schaffalitzky de Muckadell, Philip Strom, Claes Christian Drug Saf Letter to the Editor Springer International Publishing 2020-04-06 2020 /pmc/articles/PMC7165130/ /pubmed/32253716 http://dx.doi.org/10.1007/s40264-020-00929-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/. |
| spellingShingle | Letter to the Editor Schaffalitzky de Muckadell, Philip Strom, Claes Christian Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ |
| title | Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ |
| title_full | Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ |
| title_fullStr | Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ |
| title_full_unstemmed | Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ |
| title_short | Comment on ‘Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures’ |
| title_sort | comment on ‘reported severe hypersensitivity reactions after intravenous iron administration in the european economic area (eea) before and after implementation of risk minimization measures’ |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165130/ https://www.ncbi.nlm.nih.gov/pubmed/32253716 http://dx.doi.org/10.1007/s40264-020-00929-0 |
| work_keys_str_mv | AT schaffalitzkydemuckadellphilip commentonreportedseverehypersensitivityreactionsafterintravenousironadministrationintheeuropeaneconomicareaeeabeforeandafterimplementationofriskminimizationmeasures AT stromclaeschristian commentonreportedseverehypersensitivityreactionsafterintravenousironadministrationintheeuropeaneconomicareaeeabeforeandafterimplementationofriskminimizationmeasures |